JP Morgan Initiates Coverage On Ardent Health Partners with Neutral Rating, Announces Price Target of $18
Portfolio Pulse from Benzinga Newsdesk
JP Morgan has initiated coverage on Ardent Health Partners (NYSE:ARDT) with a Neutral rating and set a price target of $18.
August 12, 2024 | 10:33 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
JP Morgan has initiated coverage on Ardent Health Partners with a Neutral rating and set a price target of $18.
The Neutral rating suggests that JP Morgan does not expect significant short-term movement in ARDT's stock price. The price target of $18 provides a benchmark for investors.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100